• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session

    8/30/22 1:23:20 PM ET
    $AA
    $AHI
    $AMST
    $AMWD
    Aluminum
    Industrials
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $AA alert in real time by email

    Gainers

    • NewAge, Inc. (NASDAQ:NBEV) rose 54.4% to $0.3220.
    • IN8bio, Inc. (NASDAQ:INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02. HC Wainwright & Co. initiated coverage on IN8bio with a Buy rating and announced a price target of $14.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares jumped 45% to $3.7705. Shares are in low-float territory; the issue has about 15 million shares in its float.
    • Forge Global Holdings, Inc. (NYSE:FRGE) gained 26.7% to $4.37.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) gained 20% to $3.94.
    • American Outdoor Brands, Inc. (NASDAQ:AOUT) surged 18% to $9.17 after B. Riley upgraded the stock from Neutral to Buy and announced an $11 price target.
    • P3 Health Partners Inc. (NASDAQ:PIII) jumped 16.8% to $5.63. P3 Health Partners expanded its footprint in Nevada.
    • TMC the metals company Inc. (NASDAQ:TMC) gained 16.6% to $0.98. The company recently posted a quarterly loss of $0.05 per share.
    • OKYO Pharma Limited (NASDAQ:OKYO) gained 15.9% to $2.33. OKYO Pharma plans Q4 IND filing of OK-101 to treat dry eye disease with subsequent Phase 2 initiation.
    • FaZe Holdings Inc. (NASDAQ:FAZE) gained 14% to $19.37.
    • Hour Loop, Inc. (NASDAQ:HOUR) jumped 13.7% to $3.7300.
    • American Woodmark Corporation (NASDAQ:AMWD) gained 13.2% to $53.72 after reporting better-than-expected Q1 results.
    • Barfresh Food Group, Inc. (NASDAQ:BRFH) rose 12.1% to $3.81.
    • Avid Technology, Inc. (NASDAQ:AVID) gained 11.7% to $26.96. Avid Technology will replace Plantronics in the S&P SmallCap 600 on Thursday, September 1.
    • Check-Cap Ltd. (NASDAQ:CHEK) rose 11.4% to $0.4598 after gaining over 4% on Monday.
    • ECMOHO Limited (NASDAQ:MOHO) rose 11.4% to $0.1637.
    • Arco Platform Limited (NASDAQ:ARCE) gained 10% to $14.57. JP Morgan upgraded Arco Platform from Neutral to Overweight and lowered the price target from $21 to $20.
    • Sharps Technology, Inc. (NASDAQ:STSS) rose 7.9% to $1.50.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares gained 5.6% to $3.01 after a 13D Filing showed Cincinnati Cornerstone Investors reported a 22.9% stake in the company.
    • Big Lots, Inc. (NYSE:BIG) surged 4.8% to $22.58 after the company reported a second-quarter FY22 sales decline of 7.6% year-on-year to $1.346 billion, marginally beating the consensus of $1.34 billion. Comparable sales decreased 9.2%.


    Losers

    • Amesite Inc. (NASDAQ:AMST) shares dropped 46.4% to $0.4458 after the company announced a $2.3 million registered direct offering.
    • Baudax Bio, Inc. (NASDAQ:BXRX) shares fell 40% to $0.3275 after the company reported pricing of $6.2 million public offering.
    • Liquidia Corporation (NASDAQ:LQDA) declined 28.3% to $5.54.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) fell 26.5% to $6.15 on profit-taking after the stock surged following its IPO.
    • Sentage Holdings Inc. (NASDAQ:SNTG) shares dipped 26% to $3.70 on possible profit taking after the stock surged Monday.
    • The OLB Group, Inc. (NASDAQ:OLB) fell 25% to $1.50.
    • Photronics, Inc. (NASDAQ:PLAB) fell 23% to $16.76. Photronics posted upbeat Q3 results, but issued weak outlook for the current quarter.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 21.3% to $1.0394. Advanced Human Imaging shares jumped 94% on Monday after the company announced it signed a Master Services Agreement with Activate Health OÜ.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) declined 21.1% to $5.08 as the stock sees volatility following its IPO last Tuesday.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) dropped 17.9% to $1.03. Morgan Stanley downgraded Cabaletta Bio from Overweight to Equal-Weight and lowered the price target from $15 to $3.
    • Veru Inc. (NASDAQ:VERU) fell 17.8% to $13.56.
    • Cross Timbers Royalty Trust (NYSE:CRT) fell 17.8% to $20.23. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Azure Power Global Limited (NYSE:AZRE) dropped 17.5% to $4.83 after Credit Suisse downgraded the stock from Outperform to Underperform and lowered its price target from $22 to $5.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 17.5% to $0.1295. Clarus Therapeutics shares dipped 23% on Monday after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 17.5% to $1.1550.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) declined 17.3% to $2.4389.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) dropped 16.8% to $3.5650 after the company reported top line data from Phase 2 SELECT trial evaluating Vopratelimab.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) fell 16.8% to $5.49.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) dropped 16.6% to $7.64.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) declined 16.1% to $1.8450. The company recently priced its IPO at $5 per unit.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) declined 14.9% to $0.1968. Ladenburg Thalmann recently initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
    • BrainsWay Ltd. (NASDAQ:BWAY) fell 14% to $4.0001. The FDA, on Monday, granted 510(k) clearance to BrainsWay Ltd's (NASDAQ:BWAY) Deep Transcranial Magnetic Stimulation (TMS) H7 Coil for its use in treating adults suffering from major depressive disorder and depression, including those with comorbid anxiety symptoms commonly known as anxious depression.
    • REX American Resources Corporation (NYSE:REX) dropped 13.9% to $28.95. The company reported upbeat quarterly earnings.
    • Silver Crest Acquisition Corporation (NASDAQ:SLCR) fell 12.5% to $8.88.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) dipped 12.5% to $0.8750.
    • Houston American Energy Corp. (NYSE:HUSA) dropped 11.9% to $4.37.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) fell 10.6% to $5.43.
    • Marpai, Inc. (NASDAQ:MRAI) fell 9.8% to $0.9198.
    • iQIYI, Inc. (NASDAQ:IQ) declined 9% to $3.5750 after the company reported Q2 earnings results.
    • Alcoa Corporation (NYSE:AA) dropped 8.6% to $50.71. Alcoa to curtail one third of production capacity at Lista Smelter in Norway to mitigate high energy costs.
    • Nikola Corporation (NASDAQ:NKLA) fell 8.1% to $5.49 after the company filed a prospectus related to the issuance and sale of common stock from time to time up to $400 million. The company also announced an exchange offer to purchase all outstanding shares of Romeo Power.
    • Helmerich & Payne, Inc. (NYSE:HP) dropped 6.6% to $42.43. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Baidu, Inc. (NASDAQ:BIDU) declined 6.3% to $138.06 after the company reported Q2 EPS results.
    • Cuentas Inc. (NASDAQ:CUEN) fell 5.7% to $0.68. Cuentas shares gained over 5% on Monday after the company announced it has entered into a collaboration for exclusive licensing and transaction sharing with The OLB Group to upgrade the company's Bodega network and help them evolve into financial centers.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $AHI
    $AMST
    $AMWD

    CompanyDatePrice TargetRatingAnalyst
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    Melco Resorts & Entertainment Limited
    $MLCO
    2/17/2026$9.50Neutral → Buy
    UBS
    Helmerich & Payne Inc.
    $HP
    2/9/2026$35.00 → $38.00Hold
    TD Cowen
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Alcoa Corporation
    $AA
    1/27/2026$64.00Overweight → Equal-Weight
    Morgan Stanley
    Melco Resorts & Entertainment Limited
    $MLCO
    1/16/2026$7.70Overweight → Neutral
    Analyst
    Alcoa Corporation
    $AA
    1/13/2026$71.00Overweight → Equal Weight
    Wells Fargo
    Alcoa Corporation
    $AA
    1/8/2026$50.00Neutral → Underweight
    Analyst
    More analyst ratings

    $AA
    $AHI
    $AMST
    $AMWD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kiora Pharmaceuticals Inc.

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    3/10/26 4:36:21 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Kiora Pharmaceuticals Inc.

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    3/10/26 4:37:12 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Strem Brian M. was granted 16,733 shares, increasing direct ownership by 36% to 62,598 units (SEC Form 4)

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    3/10/26 4:36:52 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AHI
    $AMST
    $AMWD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alcoa to Participate in J.P. Morgan 2026 Industrials Conference

    Alcoa Corporation ("Alcoa") will participate in a live webcast session at the J.P. Morgan Industrials Conference in Washington, D.C., on Tuesday, March 17, 2026. At 9:30 a.m. EDT, an Alcoa executive will participate in a question-and-answer session regarding Alcoa's business and outlook in the current market, including factors that could affect the present quarter's financial results. A slide presentation, to be used in connection with the conference and investor meetings, will be available on the "Investors" section of Alcoa's website, www.alcoa.com, beginning at approximately 7:00 a.m. EDT on March 17, 2026. The live webcast will be available on the "Investors" section of Alcoa's we

    3/10/26 8:30:00 AM ET
    $AA
    Aluminum
    Industrials

    Barfresh Food Group Announces $7.3 Million Convertible Note Financing

    Strategic Funding Enables Company to Own Manufacturing Facility Free and Clear, Accelerate Facility Completion, and a Framework to Unlock Over $200 Million in Revenue Capacity Funding to Accelerate Completion of 44,000 Square-Foot State-of-the-Art Manufacturing Facility; Company Reaffirms Fiscal 2026 Revenue Guidance of $30-$35 Million and EBITDA Target of $5 Million LOS ANGELES, March 09, 2026 (GLOBE NEWSWIRE) -- Barfresh Food Group Inc. (NASDAQ:BRFH), a leading provider of frozen, ready-to-blend and ready-to-drink beverages, today announced it has secured subscriptions for a $7.3 million senior convertible note financing. The proceeds will be used to pay off the existing mortgage on th

    3/9/26 9:00:00 AM ET
    $BRFH
    Packaged Foods
    Consumer Staples

    NOAA Determines TMC USA's Consolidated Deep-Seabed Mining Application is in Substantial Compliance

    Determination of substantial compliance marks a key step in the U.S. regulatory process for exploration and commercial recovery of polymetallic nodules in the Clarion Clipperton ZoneTMC USA's consolidated application lodged earlier this year covers areas previously applied over in April 2025 and increases the commercial recovery area from ~25,000 to ~65,000 km2, with an estimated resource of 619 million tonnes (Mt) of wet nodules and potential exploration upside of an additional 200 MtNOAA's updated regulatory framework allows applicants with exploration-phase data to submit a consolidated application for both an exploration license and commercial recovery permit, supporting a more efficient

    3/9/26 8:34:47 AM ET
    $TMC
    Metal Mining
    Basic Materials

    $AA
    $AHI
    $AMST
    $AMWD
    SEC Filings

    View All

    Barfresh Food Group Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BARFRESH FOOD GROUP INC. (0001487197) (Filer)

    3/9/26 9:00:55 AM ET
    $BRFH
    Packaged Foods
    Consumer Staples

    TMC the metals company Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - TMC the metals Co Inc. (0001798562) (Filer)

    3/9/26 8:43:49 AM ET
    $TMC
    Metal Mining
    Basic Materials

    Helmerich & Payne Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

    8-K - Helmerich & Payne, Inc. (0000046765) (Filer)

    3/6/26 4:37:26 PM ET
    $HP
    Oil & Gas Production
    Energy

    $AA
    $AHI
    $AMST
    $AMWD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President, Science & Tech. Binder Gwendolyn bought $24,763 worth of shares (11,312 units at $2.19), increasing direct ownership by 57% to 31,312 units (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:30 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Tomasello Shawn bought $50,322 worth of shares (22,725 units at $2.21) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:55:49 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $AHI
    $AMST
    $AMWD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on OKYO Pharma with a new price target

    Piper Sandler initiated coverage of OKYO Pharma with a rating of Overweight and set a new price target of $7.00

    2/20/26 8:25:04 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Melco Resorts & Entertainment upgraded by UBS with a new price target

    UBS upgraded Melco Resorts & Entertainment from Neutral to Buy and set a new price target of $9.50

    2/17/26 8:04:32 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    TD Cowen reiterated coverage on Helmerich & Payne with a new price target

    TD Cowen reiterated coverage of Helmerich & Payne with a rating of Hold and set a new price target of $38.00 from $35.00 previously

    2/9/26 6:46:33 AM ET
    $HP
    Oil & Gas Production
    Energy

    $AA
    $AHI
    $AMST
    $AMWD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AHI
    $AMST
    $AMWD
    Leadership Updates

    Live Leadership Updates

    View All

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

    Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli will lead the clinical and regulatory strategy to advance the company's development program in neuropathic corneal pain (NCP), leveraging urcosimod's FDA Fast Track designationThis appointment, following the recent CEO appointment, further strengthens OKYO's world-class ophthalmology leadership team LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur

    2/10/26 8:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Photronics Appoints Jeff Catlin Senior Vice President, Global Sales

    BROOKFIELD, Conn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today announced the appointment of Jeff Catlin as the company's Senior Vice President, Global Sales. Mr. Catlin will serve as the head of sales for Photronics, driving a unified strategy that will align all sales teams. Mr. Catlin brings more than two decades of leadership experience in the semiconductor industry, including over 10 years of building and managing global sales organizations that deliver measurable growth. Jeff comes to Photronics having held senior roles spanning SVP of Sales & Marketing, Head of Sales Operations, VP/GM of Patterni

    1/8/26 8:00:00 AM ET
    $PLAB
    Semiconductors
    Technology

    $AA
    $AHI
    $AMST
    $AMWD
    Financials

    Live finance-specific insights

    View All

    Alcoa Corporation Declares Quarterly Cash Dividend

    Alcoa Corporation (NYSE:AA, ASX: AAI)) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company's common stock, to be paid on March 26, 2026 to stockholders of record as of the close of business on March 10, 2026. About Alcoa Corporation Alcoa is a global industry leader in bauxite, alumina and aluminum products with a vision to build a legacy of excellence for future generations. With a values-based approach that encompasses integrity, operating excellence, care for people, and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital

    2/26/26 5:25:00 PM ET
    $AA
    Aluminum
    Industrials

    American Outdoor Brands Third Quarter Fiscal 2026 Financial Release and Conference Call Alert

    COLUMBIA, Mo., Feb. 26, 2026 /PRNewswire/ -- American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an innovation company that provides product solutions for outdoor enthusiasts, today announced that it plans to release its third quarter fiscal 2026 financial results on Thursday, March 12, 2026, after the close of the market. The full text of the press release will be available on the company's website at www.aob.com under the Investor Relations section. The company will host a conference call and webcast on Thursday, March 12, 2026, to discuss its third quarter fiscal 2026

    2/26/26 8:00:00 AM ET
    $AOUT
    Recreational Games/Products/Toys
    Consumer Discretionary

    American Woodmark Corporation Announces Third Quarter Results

    Fiscal Third Quarter 2026 Financial Highlights: Net sales of $324.3 million Net loss of $(28.7) million; (8.9)% of net sales, including a non-cash goodwill impairment charge of $30.1 million GAAP EPS of $(1.97); adjusted EPS of $0.45 Adjusted EBITDA of $21.6 million; 6.7% of net sales Fiscal 2026 Year to Date Financial Highlights: Net sales of $1,122.0 million Net loss of $(8.0) million; (0.7)% of net sales, including a non-cash goodwill impairment charge of $30.1 million GAAP EPS of $(0.55); adjusted EPS of $2.21 Adjusted EBITDA of $103.5 million; 9.2% of net sales Cash provided by operating activities of $31.1 million; free cash flow of $2.1 million Americ

    2/26/26 6:30:00 AM ET
    $AMWD
    Forest Products
    Basic Materials

    $AA
    $AHI
    $AMST
    $AMWD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care